Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center.
Larisa Renata Pantea-Roșan, Ovidiu Țica, Otilia Anca Țica, Mircea Ioachim Popescu, Iulia Bogdan, Alexandra Buzle, Mădălina Ioana Moisi, Vlad Alin Pantea
{"title":"Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center.","authors":"Larisa Renata Pantea-Roșan, Ovidiu Țica, Otilia Anca Țica, Mircea Ioachim Popescu, Iulia Bogdan, Alexandra Buzle, Mădălina Ioana Moisi, Vlad Alin Pantea","doi":"10.2478/rjim-2025-0016","DOIUrl":null,"url":null,"abstract":"<p><p>The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.</p><p><strong>Purpose: </strong>Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).</p><p><strong>Material and method: </strong>Between 01.01.2016 - 31.03.2018, we performed a prospective study including 656 patients with STEMI. We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.</p><p><strong>Results: </strong>Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died. Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.9% vs. 14.3%). The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (<i>p</i> = 0.039). Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.33% vs. 1.75%, <i>p</i> <0.001).</p><p><strong>Conclusions: </strong>The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon. Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.</p>","PeriodicalId":21463,"journal":{"name":"Romanian Journal of Internal Medicine","volume":"63 4","pages":"265-276"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/rjim-2025-0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.
Purpose: Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).
Material and method: Between 01.01.2016 - 31.03.2018, we performed a prospective study including 656 patients with STEMI. We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.
Results: Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died. Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.9% vs. 14.3%). The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (p = 0.039). Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.33% vs. 1.75%, p <0.001).
Conclusions: The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon. Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.
st段抬高急性心肌梗死(STEMI)患者的死亡率因短期和长期并发症而增加。目的:本研究旨在揭示STEMI患者经皮冠状动脉介入治疗(PCI)后出现无血流现象的死亡风险及院内死亡预测因素。材料和方法:2016年1月1日至2018年3月31日,我们进行了一项前瞻性研究,包括656例STEMI患者。我们只纳入了通过初级PCI行心肌血运重建术并出现无血流倒流现象的患者。结果:本研究纳入96例STEMI患者PCI术后无再流现象,其中14例死亡。前路STEMI患者的死亡率明显高于下路STEMI患者(42.9% vs. 14.3%)。冠状动脉无血流现象组PCI术后死亡率明显高于心肌无血流现象组(p = 0.039)。有并发症的患者pci后死亡率明显高于无并发症的患者(33.33% vs. 1.75%, p)结论:冠状动脉无再流现象死亡风险最高,占心肌无再流现象心肌梗死病例的一半以上。据报道,大多数死亡发生在STEMI和无回流现象的受试者中,他们出现了心血管并发症。